IL1B and Stroke: Only one of the studies [22] that compared add-on BHT variants (conventional therapies including rehabilitation therapies for stroke + BHT variant) with a control treatment (conventional therapies including rehabilitation therapies for stroke only) assessed the inflammatory cytokine levels of interleukin (IL)-1β, IL-6, and TNF-α.